Figure 4. Naringin attenuates oxygen-glucose deprivation/recovery (OGD/R)-induced apoptosis of cardiomyocytes via GSK-3β/β-catenin signaling pathway. (a) Western blots for GSK-3β/β-catenin signaling pathway. (b) Immunofluorescence staining for β-catenin.
NS: non-significant; *P < 0.05; **P < 0.01; ***P < 0.001, vs. the control group.